Dr. Tom Mabin,
The good attendance at this early session indicted the importance of this topic and the excellent quality of the speakers.
JS Hochman first discussed the natural history and the role of medical therapy. Emphasising the lack of RCT data, she dealt with the large meta-analysis published in AHJ 2010 and then went on to share some as yet unpublished, long term data from the OAT trial.
GS Werner discussed the role of PCI in CTO pointing out how much of a problem CTO presents in terms of revascularisation. 30 % of cath lab cases and > 3O o/o have MVD. Persistent patency is the key to benefit and this improves with experience and expertise. DES have a major role to play.
Prof Kohl dealt with the role of surgical intervention in CTO and reminded us that patients with a SYNTAX score of >22 should be considered for surgery, particularly if CTO is present. This is particularly relevant in terms of LAD revascularisation
S T Lim then spoke of future developments and concentrated on the role that newer imaging technologies will have on improving outcomes.This include using MRI for vulnerability and IVUS or guidance during the procedure. In all an excellent session. CTO remains challenging; requires patience and expertise; there is a need for RCT and long term patency is the key to success
Myocardial revascularisation for chronic total coronary oclusion
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved